Skip to main content

Articles

1215 result(s) for 'cancer' within Journal of Ovarian Research

Page 6 of 25

  1. Biochemical recurrence is defined as only rising CA-125 but no radiographic evidence of disease; noteworthily, it generally precedes the onset of clinical evidence. Now treatment strategies of biochemical recurre...

    Authors: Zhongyu Wang, Yake Huang, Ling Long, Li Zhou, Yan Huang, Lei Gan, Aimin Pu, Sufen Li and Rongkai Xie
    Citation: Journal of Ovarian Research 2021 14:91
    Content type: Research Published on:

  2. Measurement of serum CA125, an antigenic fragment of human mucin 16 (MUC16), is used to monitor the clinical progression of epithelial ovarian cancer (EOC). However, rather than simply...

    Authors: Kornél Lakatos, Germán González, Jawad Hoballah, Jeff Brooker, Sinyoung Jeong, Conor Evans, Petra Krauledat, W. Peter Hansen, Kevin M. Elias, Manish Patankar, Vilmos Fülöp, Panagiotis A. Konstantinopoulos and Daniel W. Cramer
    Citation: Journal of Ovarian Research 2022 15:28
    Content type: Research Published on:

  3. Our results showed significant upregulation of circ-PHC3 in both OC cell lines and tissues. In the luciferase reporter assay, downregulation of circ-PHC3 led to suppression of metastasis and proliferation, potent...

    Authors: Hongxia Wang, Suwei Lan, Lingxiang Wang, Jingyun Zhao, Xinzhuan Jia, Jie Xu, Guangyu Sun, Leilei Liu, Shan Gong, Na Wang, Baoen Shan, Fenghua Zhang and Zhengmao Zhang
    Citation: Journal of Ovarian Research 2023 16:142
    Content type: Research Published on:

  4. There is as yet limited evidence about fertility-sparing surgery for early ovarian cancer (EOC) carried out laparoscopically. We sought ... and fertility outcome in a cohort of ovarian cancer patients who underwe...

    Authors: Antonella Cromi, Giorgio Bogani, Stefano Uccella, Jvan Casarin, Maurizio Serati and Fabio Ghezzi
    Citation: Journal of Ovarian Research 2014 7:59
    Content type: Research Published on:

  6. Endometriosis is frequently associated with high levels of CA125. This marker is therefore not useful for discriminating ovarian endometrioma from ovarian malignancy. The aim of this study was to establish a pane...

    Authors: Emanuela Anastasi, Teresa Granato, Renato Falzarano, Paola Storelli, Adele Ticino, Luigi Frati, Pierluigi Benedetti Panici and Maria Grazia Porpora
    Citation: Journal of Ovarian Research 2013 6:44
    Content type: Research Published on:

  7. In this report we present the results of the retrospective (survival and classification) analyses of possible prognostic factors prolonging survival in epithelial ovarian cancer brain metastases patients after st...

    Authors: Agata Celejewska, Andrzej Tukiendorf, Leszek Miszczyk, Krzysztof Składowski, Jerzy Wydmański and Krystyna Trela-Janus
    Citation: Journal of Ovarian Research 2014 7:79
    Content type: Research Published on:

  10. High expression of the polymeric immunoglobulin receptor (PIGR) has previously been associated with a favourable prognosis in a few cancer forms, but its expression and relationship with clinical outcome in epith...

    Authors: Jonna Berntsson, Sebastian Lundgren, Björn Nodin, Mathias Uhlén, Alexander Gaber and Karin Jirström
    Citation: Journal of Ovarian Research 2014 7:26
    Content type: Research Published on:

  11. Growing evidence indicates that lncRNA colon cancer-associated transcript 2 (CCAT2) is associated with cancers. However, the clinical value of CCAT2 in cervical cancer (CC) remains unclear. In this study...P < 0....

    Authors: Xiaoli Cao, Juan Yao, Meiqun Jia, Xianjuan Shen, Jinye Zhang and Shaoqing Ju
    Citation: Journal of Ovarian Research 2022 15:20
    Content type: Research Published on:

  12. Resistance to platinum-based chemotherapy is one of the crucial problems in ovarian cancer treatment. Ghrelin, a widely distributed peptide hormone, participates in a series of cancer progression. The aim of this...

    Authors: Yun Leng, Can Zhao, Guoliang Yan, Shuangyue Xu, Yinggui Yang, Ting Gong, Xin Li and Chenglin Li
    Citation: Journal of Ovarian Research 2021 14:162
    Content type: Research Published on:

  13. We aimed to explore role of lncRNA PAX-interacting protein 1-antisense RNA1 (PAXIP1-AS1) in ovarian cancer (OC). RT-qPCR analysis identified upregulation...

    Authors: Yimin Ma and Wei Zheng
    Citation: Journal of Ovarian Research 2021 14:76
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Ovarian Research 2022 15:108

  15. Cyclin-dependent kinase 9 (CDK9) has been shown to play an important role in tumorigenesis of several malignancies. However, the expression of CDK9 in ovarian cancer from Middle Eastern ethnicity remains unknown.

    Authors: Sandeep Kumar Parvathareddy, Abdul K. Siraj, Tariq Masoodi, Padmanaban Annaiyappanaidu, Ismail A. Al-Badawi, Fouad Al-Dayel and Khawla S. Al-Kuraya
    Citation: Journal of Ovarian Research 2021 14:69
    Content type: Research Published on:

  17. MicroRNAs (miRNAs) have been implicated to play a vital role in development, differentiation, cell proliferation and apoptosis. However, which miRNAs are actually associated with endometriosis-associated ovarian

    Authors: Natsuho Nakamura, Yoshito Terai, Misa Nunode, Kana Kokunai, Hiromi Konishi, Sayaka Taga, Mayumi Nakamura, Masae Yoo, Masami Hayashi, Yoshiki Yamashita and Masahide Ohmichi
    Citation: Journal of Ovarian Research 2020 13:51
    Content type: Research Published on:

  18. Since ovarian cancer is associated with high frequency of p53...p 53 r eactivation and i nduction of m assive a...poptosis (PRIMA-1) offers a possible new therapeutic strategy for overcoming this devastating dise...

    Authors: Noriko Kobayashi, Mohammadreza Abedini, Noriaki Sakuragi and Benjamin K Tsang
    Citation: Journal of Ovarian Research 2013 6:7
    Content type: Research Published on:

  19. Primary debulking surgery (PDS) is the main treatment for patients with advanced ovarian cancer, and neoadjuvant chemotherapy (NACT) is for...

    Authors: Dengfeng Wang, Guonan Zhang, Chunrong Peng, Yu Shi and Xunwei Shi
    Citation: Journal of Ovarian Research 2021 14:49
    Content type: Research Published on:

  22. There are about 2.4 hundred thousand new cases and 1.5 hundred thousand deaths of ovarian cancer (OC) annually in the world. Chronic ... may facilitate inflammation and transactivate EGFR in ovarian cancer, but t...

    Authors: Man Guo, Chao Xu, Yan-Zhe Chen, Qi-Wen Sun, Xin-Ying Zhao, Xin Liu, Yi Yang, Yi-Yan Hu, Fei-Feng Li and Shu-Lin Liu
    Citation: Journal of Ovarian Research 2020 13:43
    Content type: Research Published on:

  23. Ovarian cancer (OC) is a leading cause of cancer-related death in women, and thus an ... exosomal microRNA-34a (miR-34a) in ovarian cancer could be used as a potential biomarker.

    Authors: Kazuya Maeda, Hiroshi Sasaki, Shoko Ueda, Shunsuke Miyamoto, Shinichi Terada, Hiromi Konishi, Yuhei Kogata, Keisuke Ashihara, Satoe Fujiwara, Yoshimichi Tanaka, Tomohito Tanaka, Masami Hayashi, Yuko Ito, Yoichi Kondo, Takahiro Ochiya and Masahide Ohmichi
    Citation: Journal of Ovarian Research 2020 13:47
    Content type: Research Published on:

  24. As one of the main gynecological cancers, ovarian cancer (OC) has an unfavourable outcomes owing ... 29c-3p inhibition. In sum up, the cancer-promoting function of LINC01296 was achieved by...

    Authors: Hui Xu, Hong-Luan Mao, Xin-Rui Zhao, Yue Li and Pei-Shu Liu
    Citation: Journal of Ovarian Research 2020 13:31
    Content type: Research Published on:

  25. The aim of this study is to establish a noninvasive preoperative model for predicting primary optimal cytoreduction in advanced epithelial ovarian cancer by HE4 and CA125 combined with clinicopathological...

    Authors: Li-yuan Feng, Sheng-bin Liao and Li Li
    Citation: Journal of Ovarian Research 2020 13:17
    Content type: Research Published on:

  29. The capacity of nadir CA-125 levels to predict the prognosis of epithelial ovarian cancer remains controversial. This study aimed to explore ... ) in patients with high-grade serous ovarian cancer (HG-SOC) from t...

    Authors: Xia Xu, Yan Wang, Fang Wang, Lizhou Jia, Yiqin Zhou, Fei Deng, Junwei Qu, Bifang Zhou, Aifeng Meng, Bole Fu, Xiaoxiang Chen, Zhiying Qian and Jinhua Wang
    Citation: Journal of Ovarian Research 2013 6:31
    Content type: Research Published on:

  30. The age of 12 patients diagnosed with ovarian seromucinous carcinoma ranged from 23 to 68 years, with a median age of 46.8 years. Serum level of CA125 was elevated in 10 patients, and CA125/CEA ratio was less tha...

    Authors: Yi Hu, Kun Fu, Huining Liu, Qiongqiong He, Xiaoqin Qiu, Wenqing Yang and Yu Zhang
    Citation: Journal of Ovarian Research 2023 16:18
    Content type: Research Published on:

  32. In clinical practice alterations in CA-125 concentration within normal range in patients with ovarian cancer after first-line treatment are common. Even ... reference level in patients who suffered from ovarian cancer

    Authors: Szymon Piatek, Grzegorz Panek, Zbigniew Lewandowski, Mariusz Bidzinski, Dominika Piatek, Przemyslaw Kosinski and Miroslaw Wielgos
    Citation: Journal of Ovarian Research 2020 13:102
    Content type: Research Published on:

  33. In this study we found that CTBP1-AS2 was downregulated in EC and correlated with poor survival. MiR-216a might form base pairs with CTBP1-AS2 based on RNA-RNA interaction, which was confirmed by luciferase activ...

    Authors: Qing-an-zi Wang, Yongxiu Yang and Xiaolei Liang
    Citation: Journal of Ovarian Research 2020 13:37
    Content type: Research Published on:

    The Retraction Note to this article has been published in Journal of Ovarian Research 2020 13:147

  34. Exosomal miRNAs are known to play important roles in ovarian cancer and chemotherapeutic resistance. However, a systematic ... exosomal miRNAs involved in cisplatin resistance in ovarian cancer remains totally un...

    Authors: Huihui Wang, Li Liu, Qinying Liu, Jianfeng Zheng, Qiuhong Zheng, Yuwei Chen, Hongmei Xia, Qiaoling Wu and Yang Sun
    Citation: Journal of Ovarian Research 2023 16:94
    Content type: Research Published on:

  35. Dexamethasone (DEX) has been routinely used as a pre-treatment in the clinical application of paclitaxel (PTX) to treat ovarian cancer. However, PTX-induced apoptosis might be...

    Authors: Wenjing Hou, Jianhua Guan, Huan Lu, Qian Dong, Yuhong Han and Rong Zhang
    Citation: Journal of Ovarian Research 2014 7:89
    Content type: Research Published on:

    The Retraction Note to this article has been published in Journal of Ovarian Research 2015 8:16

  36. The efficacy of subsequent therapy after poly-ADP-ribose polymerase (PARP) inhibitor maintenance treatment has raised concerns. Retrospective studies show worse outcomes for platinum-based chemotherapy after prog...

    Authors: Nan Zhang, Hong Zheng, Yunong Gao, Tong Shu, Hongguo Wang and Yan Cai
    Citation: Journal of Ovarian Research 2024 17:55
    Content type: Research Published on:

  37. Dysregulation of Ectonucleoside Triphospahate Diphosphohydrolase 5 (ENTPD5) in tumors might be associated with tumor progression, while the role of ENTPD5 in the growth and metastasis of serous ovarian cancer (SO...

    Authors: Xueping Chen, Zhiqiang Zha, Yu Wang, Yun Chen, Menglan Pang, Liping Huang and Yao Chen
    Citation: Journal of Ovarian Research 2022 15:69
    Content type: Research Published on:

  38. Early detection of ovarian cancer remains a challenge due to widespread metastases ... for both laparoscopic and serum diagnostics in ovarian cancer.

    Authors: Ayala Tamir, Ushma Jag, Sreeja Sarojini, Craig Schindewolf, Takemi Tanaka, Rajendra Gharbaran, Hiren Patel, Anil Sood, Wei Hu, Ruzeen Patwa, Patrick Blake, Polina Chirina, Jin Oh Jeong, Heejin Lim, Andre Goy, Andrew Pecora…
    Citation: Journal of Ovarian Research 2014 7:109
    Content type: Research Published on:

  39. To explore the effect of intervention programs constructed under the guidance of the comprehensive unit-based safety program (CUSP) model on chemotherapy-induced nausea and vomiting (CINV) in patients with ovaria...

    Authors: Aihua Liu, Min Li, Zhuo Liu, Xinxin Xie, Wen Yao, Jingmin Wang, Tingting Zhao and Jie Yang
    Citation: Journal of Ovarian Research 2023 16:143
    Content type: Research Published on:

  43. A retrospective real-word study included 658 patients with histologically confirmed advanced epithelial ovarian cancer who received NACT at seven tertiary hospitals...

    Authors: Xingyu Liu, Yingjun Zhao, Xiaofei Jiao, Yang Yu, Ruyuan Li, Shaoqing Zeng, Jianhua Chi, Guanchen Ma, Yabing Huo, Ming Li, Zikun Peng, Jiahao Liu, Qi Zhou, Dongling Zou, Li Wang, Qingshui Li…
    Citation: Journal of Ovarian Research 2023 16:121
    Content type: Research Published on:

  44. Resistance to chemotherapy continues to be a challenge when treating epithelial ovarian cancer (EOC), contributing to low patient survival...

    Authors: Emma Gerber, Meshach Asare-Werehene, Arkadiy Reunov, Dylan Burger, Tien Le, Euridice Carmona, Anne-Marie Mes-Masson and Benjamin K. Tsang
    Citation: Journal of Ovarian Research 2023 16:14
    Content type: Research Published on:

  45. Ovarian cancer (OvCa) is one of the most...Byrsocarpus coccineus plant preparation has been administered to patients traditionally in the management of tumors in Nigeria. In this study, we investigated the anti-p...

    Authors: Caroline E. Ukwade, Osaretin A. T. Ebuehi, Rahmat A. Adisa, Santosh K. Singh and Rajesh Singh
    Citation: Journal of Ovarian Research 2020 13:83
    Content type: Research Published on:

  46. Copy number variation (CNVs) is a key factor in breast cancer development. This study determined prognostic molecular characteristics to predict breast cancer through performing a comprehensive analysis of copy.....

    Authors: Wei Hu, Mingyue Li, Qi Zhang, Chuan Liu, Xinmei Wang, Jing Li, Shusheng Qiu and Liang Li
    Citation: Journal of Ovarian Research 2021 14:103
    Content type: Research Published on:

  47. In view of the recent association of Brn-3 transcription factors with neuroblastomas, cervical, breast, and prostate cancers we examined the expression of Brn-3a( ... ) was also evaluated in normal ovarian and cancer

    Authors: Nuzhat Ahmed, Ardian Latifi, Clyde B Riley, Jock K Findlay and Michael A Quinn
    Citation: Journal of Ovarian Research 2010 3:17
    Content type: Research Published on:

  48. The standard treatment of ovarian cancer with chemotherapy often leads to drug resistance ... which is expressed by the majority of epithelial cancers including ovarian carcinomas, and we studied the cytotoxic ef...

    Authors: Merete Thune Wiiger, Hemaseh Bideli, Øystein Fodstad, Kjersti Flatmark and Yvonne Andersson
    Citation: Journal of Ovarian Research 2014 7:23
    Content type: Research Published on:

  49. Previous meta-analysis studies suggested that pegylated liposomal doxorubicin (PLD) may improve the survival rate of patients with recurrent ovarian cancer. The aim of the present meta-analysis ... of PLD in the ...

    Authors: Xin-Ru Li, Yi Zhu, Guo-Nan Zhang, Jian-Ming Huang and Li-Xia Pei
    Citation: Journal of Ovarian Research 2021 14:42
    Content type: Research Published on:

  50. Long noncoding RNA (lncRNA) LINC00922 has been reported to promote tumorigenesis of lung and breast cancer. However, the functions and mechanisms of LINC00922 in ovarian cancer (OC) remain unclarified. The curren...

    Authors: Liping Wang, Chenchen Ren, Yajuan Xu, Li Yang, Yannan Chen and Yuanhang Zhu
    Citation: Journal of Ovarian Research 2021 14:77
    Content type: Research Published on:
Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

Editor News

New Content ItemEditor-in-Chief Dr Ben Tsang has been recognised by the Canadian Parliament for significant contributions to science. Please join us in celebrating this amazing achievement.

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.

Journal of Ovarian Research

ISSN: 1757-2215

Contact us